Childhood Epilepsy clinical trials

Explore recruiting childhood epilepsy clinical trials.

Recruiting childhood epilepsy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Childhood Epilepsy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label Study with Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy

Germany, Belgium, Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Childhood Epilepsy trials by city

Childhood Epilepsy in Toronto Childhood Epilepsy in Vancouver Childhood Epilepsy in Montreal Childhood Epilepsy in Calgary Childhood Epilepsy in Edmonton Childhood Epilepsy in Ottawa Childhood Epilepsy in Winnipeg Childhood Epilepsy in Quebec City Childhood Epilepsy in Hamilton Childhood Epilepsy in Kitchener Childhood Epilepsy in London Childhood Epilepsy in Halifax Childhood Epilepsy in New York Childhood Epilepsy in Los Angeles Childhood Epilepsy in Chicago Childhood Epilepsy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease